Cohen S - Search Results

1

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.

Kakiuchi-Kiyota S, Ross T, Wallweber HA, Kiefer JR, Schutten MM, Adedeji AO, Cai H, Hendricks R, Cohen S, Myneni S, Liu L, Fullerton A, Corr N, Yu L, de Almeida Nagata D, Zhong S, Leong SR, Li J, Nakamura R, Sumiyoshi T, Li J, Ovacik AM, Zheng B, Dillon M, Spiess C, Wingert S, Rajkovic E, Ellwanger K, Reusch U, Polson AG. Kakiuchi-Kiyota S, et al. Among authors: cohen s. Leukemia. 2022 Apr;36(4):1006-1014. doi: 10.1038/s41375-021-01478-w. Epub 2022 Jan 10. Leukemia. 2022. PMID: 35001074

2

Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells.

Cohen S, Myneni S, Batt A, Guerrero J, Brumm J, Chung S. Cohen S, et al. MAbs. 2021 Jan-Dec;13(1):1898831. doi: 10.1080/19420862.2021.1898831. MAbs. 2021. PMID: 33729092 Free PMC article.

3

An integrated approach for characterizing immunogenic responses toward a bispecific antibody.

Cohen S, Chung S, Spiess C, Lundin V, Stefanich E, Laing ST, Clark V, Brumm J, Zhou Y, Huang C, Guerrero J, Myneni S, Yadav R, Siradze K, Peng K. Cohen S, et al. MAbs. 2021 Jan-Dec;13(1):1944017. doi: 10.1080/19420862.2021.1944017. MAbs. 2021. PMID: 34225571 Free PMC article.

4

In vitro immunogenicity prediction: bridging between innate and adaptive immunity.

Cohen S, Chung S. Cohen S, et al. Bioanalysis. 2021 Jul;13(13):1071-1081. doi: 10.4155/bio-2021-0077. Epub 2021 Jun 14. Bioanalysis. 2021. PMID: 34124935 Review.

5

The immunogenicity of human-origin therapeutic antibodies are associated with V gene usage.

Hu Z, Cohen S, Swanson SJ. Hu Z, et al. Among authors: cohen s. Front Immunol. 2023 Sep 1;14:1237754. doi: 10.3389/fimmu.2023.1237754. eCollection 2023. Front Immunol. 2023. PMID: 37720227 Free PMC article.

6

Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies.

Harris CT, Cohen S. Harris CT, et al. Among authors: cohen s. BioDrugs. 2024 Mar;38(2):205-226. doi: 10.1007/s40259-023-00641-2. Epub 2024 Jan 23. BioDrugs. 2024. PMID: 38261155 Free PMC article. Review.

7

Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity.

Thrift WJ, Perera J, Cohen S, Lounsbury NW, Gurung HR, Rose CM, Chen J, Jhunjhunwala S, Liu K. Thrift WJ, et al. Among authors: cohen s. Brief Bioinform. 2024 Mar 27;25(3):bbae123. doi: 10.1093/bib/bbae123. Brief Bioinform. 2024. PMID: 38555476 Free PMC article.

8

Application of N-Terminal Site-Specific Biotin and Digoxigenin Conjugates to Clinical Anti-drug Antibody Assay Development.

Wang X, Chang W, Khosraviani M, Phung W, Peng L, Cohen S, Andrews BT, Sun Y, Davies CW, Koerber JT, Yang J, Song A. Wang X, et al. Among authors: cohen s. Bioconjug Chem. 2024 Feb 21;35(2):174-186. doi: 10.1021/acs.bioconjchem.3c00421. Epub 2023 Dec 5. Bioconjug Chem. 2024. PMID: 38050929

9

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.

Tung N, Ricker C, Messersmith H, Balmaña J, Domchek S, Stoffel EM, Almhanna K, Arun B, Chavarri-Guerra Y, Cohen SA, Cragun D, Crew KD, Hall MJ, Idos G, Lopez G, Pal T, Pirzadeh-Miller S, Pritchard C, Rana HQ, Swami U, Vidal GA. Tung N, et al. Among authors: cohen sa. J Clin Oncol. 2024 May 17:JCO2400662. doi: 10.1200/JCO.24.00662. Online ahead of print. J Clin Oncol. 2024. PMID: 38759122

10

Electronic Nicotine-Delivery Systems for Smoking Cessation.

Borm FJ, Cohen S, Cohen D. Borm FJ, et al. Among authors: cohen s. N Engl J Med. 2024 May 16;390(19):1829-1830. doi: 10.1056/NEJMc2403709. N Engl J Med. 2024. PMID: 38749043 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,549 results

Search Page